NCT00666809View on ClinicalTrials.gov

Vardenafil in Tinnitus

PHASE2CompletedINTERVENTIONAL

Enrollment

43

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

May 31, 2007

Conditions

Tinnitus

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

Vardenafil 10 mg BID p.o. for 12 weeks + 4 weeks follow-up

DRUG

Placebo

Placebo BID p.o. for 12 weeks + 4 weeks follow-up

Trial Locations (1)

10117

Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT00666809 - Vardenafil in Tinnitus | Biotech Hunter | Biotech Hunter